IL-6 antisense-mediated growth inhibition of a choriocarcinoma cell line: An intracellular autocrine growth mechanism

Gynecologic Oncology

Volumn 63, Issue 1, 1996, Pages 78-84

  Kong, Beihua ^a   Isozaki, Taichi ^a,b   Sasaki, Shigeru ^a  

^a NIPPON MEDICAL SCHOOL   (Japan)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTISENSE OLIGONUCLEOTIDE; GLYCOPROTEIN GP 130; INTERLEUKIN 6; INTERLEUKIN 6 RECEPTOR; RECOMBINANT INTERLEUKIN 6;

ARTICLE; CHORIOCARCINOMA; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; GROWTH INHIBITION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SOUTHERN BLOTTING; TUMOR GROWTH;

EID: 0030271423     PISSN: 00908258     EISSN: None     Source Type: Journal    
DOI: 10.1006/gyno.1996.0282     Document Type: Article

References (37)

1. Cross, M., and Deter, T. M. Growth factors in development, transformation, and tumorigenesis, Cell 64, 271-280 (1991).
2. Kishimoto, T., Akira, S., Narazaki, M., and Taga, T. Interleukin-6 family of cytokine and gp130, Blood 86, 1243-1254 (1995).
3. Kawano, M., Hirano, T., Matsuda, T., Taga, T., Horii, Y., Iwato, K., Asaoka, H., Tang, B., Tanabe, O., Tanaka, H., Kuramato, A., and Kishimoto, T. Autocrine generation and requirement of BSF-2/IL-6 for human multiple myelomas, Nature 332, 83-85 (1998).
4. Levy, Y., Tsapis, A., and Brouet, J. C. Interleukin-6 antisense oligonucleotides inhibit the growth of human myeloma cell lines, J. Clin. Invest. 88, 696-699 (1991).
5. Schwab, G., Siegall, C. B., Arden, L. A., Neckers, L. M., and Nordan, R. P. Characterization of an IL-6-mediated growth loop in the human multiple myeloma cell line, U266, Blood 77, 587-593 (1991).
6. Klein, B., Zhang, X. G., Jourdan, M., Content, J., Houssiau, F., Aarden, L., Piechaczyk, M., and Bataille, R. Paracrine rather than autocrine regulation of myeloma - Cell growth and differentiation by interleukin-6, Blood 73, 517-526 (1989).
7. Eustace, D., Han, X., Gooding, R., Rowbottom, A., Riches, P., and Heyderman, E. Interleukin-6 (IL-6) functions as an autocrine growth factor in cervical carcinoma in vitro, Gynecol. Oncol. 50, 15-19 (1992).
8. Tartour, E., Gey, A., Sastre-garau, X., Pannetier, C., Mossed, V., Kourilsky, P., and Fridman, W. H. Analysis of interleukin 6 gene expression in cervical neoplasia using a quantitative polymerase chain reaction assay: Evidence for enhanced interleukin 6 gene expression in invasive carcinoma, Cancer 54, 6243-6248 (1994).
9. Scambia, G., Testa, U., Panici, P. B., Martucci, R., Foti, E., Petrini, M., Amoroso, M., Masciullo, V., Peschle, C., and Mancuso, S. Interleukin-6 serum levels in patients with gynecological tumors, Int. J. Cancer 57, 318-323 (1994).
10. Watson, J. M., Ferek, J. S., and Martinez-maza, O. Growth inhibition of ovarian cancer cells induced by antisense IL-6 oligonucleotides, Gynecol. Oncol. 49, 8-15 (1993).
11. 2, Proc. Natl Acad. Sci. USA 85, 8037-8041 (1988).
12. Takizawa, H., Ohtoshi, T., Ohta, K., Yamashita, N., Hirohata, S., Hirai, K., Hiramatsu, K., and Ito, K. Growth inhibition of human lung cancer cell lines by interleukin-6 in vitro: A possible role in tumor growth via an autocrine mechanism, Cancer Res. 53, 4175-4181 (1993).
13. Serve, H., Steinhauster, G., Oberberg, D., Flegel, W. A., Northoff, H., and Berdel, W. E. Studies on the interaction between interleukin-6 and human malignant nonhematopoietic cell lines, Cancer Res. 51, 3862-3866 (1991).
14. Lu, C., and Kerbel, R. S. Interleukin-6 undergoes transition from para-crine growth inhibitor to autocrine stimulator during human melanoma progression, J. Cell Biol. 120, 1281-1288 (1993).
15. Taniguchi, T., Matsuzaki, N., Jo, T., Saji, F., Taga, T., Hirano, T., Kishimoto, T., and Tanizawa, O. Interleukin-1 (IL-1)-induced IL-6-receptor-mediated release of human chorionic gonadotropin by choriocarcinoma cell lines (Jar and HCCM-5) activates adenosine 3′,5′-monophosphate-independent signal transduction pathway, J. Clin. Endocrinol. Metab. 74, 1389-1395 (1992).
16. Stephanou, A., and Handwerger, S. Interleukin-6 stimulates placental lactogen expression by human trophoblast cells, Endocrinology 135, 719-723 (1994).
17. Shaarawy, M., and Darwish, N. A. Serum cytokines in gestational trophoblastic diseases, Acta Oncol. 34, 177-182 (1995).
18. Miles, S. A., Rezai, A. R., Salazar-Gonzalez, J. F., Meyden, M. V., Stevens, R. H., Logan, D. M., Mitsuyasu, R. T., Taga, T., Hirano, T., Kishimoto, T., and Martinez-Maza, O. AIDS Kaposi sarcoma-derived cells produce and respond to interleukin 6, Proc. Natl. Acad. Sci. USA 87, 4068-4072 (1990).
19. Hirano, T., Yasugawa, K., Harada, H., Taga, T., Watanabe, Y., Matsuda, T., Kashiwamura, S., Nakajima, K., Koyama, K., Iwamatsu, A., Tsunasawa, S., Sakiyama, F., Matsui, H., Takahara, Y., Taniguchi, T., and Kishimoto, T. Complementary DNA for a novel human interleukin (BSF-2) that induces B lymphocytes to produce immunoglobulin, Nature 324, 73-76 (1986).
20. 2) receptor, Science 241, 825-828 (1988).
21. Hibi, M., Murakami, M., Satao, M., Hirano, T., Taga, T., and Kishimoto, T. Molecular cloning and expression of an IL-6 signal transducer, gp130, Cell 63, 1149-1157 (1990).
22. Sporn, M. B., and Todaro, G. J. Autocrine secretion and malignant transformation of cells, N. Engl. J. Med. 303, 878-880 (1980).
23. Stromberg, K., Collins, T. J., Gordon, W., Ackson, C. L., and Johnson, G. R. Transforming growth factor acts as an autocrine growth factor in ovarian carcinoma cell lines, Cancer Res. 52, 341-347 (1992).
24. Yee, C., Biondi, A., Wang, X. H., Iscove, N. N., Sousa, J. D., Aarden, L. A., Wong, G. G., Clark, S. C., Messner, H. A., and Miden, M. D. A possible autocrine role for Interleukin-6 in two lymphoma cell lines, Blood 74, 798-804 (1989).
25. Okada, K., Shimizu, Y., Nambu, S., Higuchi, K., and Watanabe, A. Interleukin-6 functions as an autocrine growth factor in a cholangiocarcinoma cell line, J. Gastroenterol. Hepatol. 9, 462-467 (1994).
26. Nagel, K. M., Holstad, S. G., and Isenberg, K. E. Oligonucleotide pharmacotherapy: An antisense strategy, Pharmacotherapy 13, 177-188 (1993).
27. Helene, C. Rational design of sequence-specific oncogene inhibitors based on antisense and antigene oligonucleotides, Eur. J. Cancer 27, 1466-1471 (1991).
28. Krieg, A. M. Applications of antisense oligonucleotides in immunology and autoimmunity research, Immunomethods 1, 191-202 (1992).
29. Lang, G. A., and Burgess, A. W. Autocrine growth factors and tumorigenic transformation, Immunol. Today 11, 244-249 (1990).
30. Motro, B., Itin, A., Sachs, L., and Keshet, E. Pattern of interleukin-6 gene expression in vivo suggests a role for this cytokine in angiogenesis, Proc. Natl. Acad. Sci. USA 87, 3092-3096 (1990).
31. Tamm, I., Cardinale, I., Krueger, J., Murphy, J. S., May, L. T., and Sehgel, P. B. Interleukin-6 decreases cell-cell association and increases motility of ductal breast carcinoma cells, J. Exp. Med. 170, 1649-1669 (1989).
32. Reibnegger, G., Krainer, M., Herold, M., Ludwig H., Wachter, H., and Huber, H. Predictive value of interleukin-6 and neopterin in patients with multiple myeloma, Cancer Res. 51, 6250-6253 (1991).
33. Tartour, E., Dorval, T., Mosseri, V., Deneux, L., Mathiot, C., Brailly, H., Montero, F., Joyeux, I., Pouillart, P., and Fridman, W. H. Serem interleukin-6 and c-reactive protein levels correlate with resistance to IL-2 therapy and poor survival in melanoma patients, Br. J. Cancer 69, 911-913 (1994).
34. Van meir, E., Savamura, Y., Diserens, A-C., Hamou, M. F., and De Tribolet, N. Human glioblastoma cells release interleukin 6 in vivo and in vitro, Cancer Res. 50, 6683-6688 (1990).
35. Santhanam, U., Ray, A., and Sehgal, P. B. Repression of the interleukin 6 gene promoter by p53 and the retinoblastoma susceptibility gene product, Proc. Natl. Acad. Sci. USA 88, 7605-7609 (1991).
36. Yaginuma, Y., Yamashita, T., Takuma, N., Katayama, H., and Ishikawa, M. Analysis of the p53 gene in human choriocarcinoma cell lines, Br. J. Cancer 71, 9-12 (1995).
37. Sasaki, S., Ohta, Y., Isozaki, T., Nomura, N., Araki, T., and Pattillo, R. A. Study on expression and amplification of c-oncogenes in choriocarcinoma cell lines, Tumor Infect. 3, 181-190 (1990).